李为民,刘怡希

• 1:哈尔滨医科大学附属第一医院心内科

摘要(Abstract)：

<正>晚近,心脏重构的研究正逐步深入。心力衰竭研究中,重构具有多重意义,从最早提出结构重构开始,到新近代谢重构的概念,大量实验与临床研究证实,重构与心力衰竭关系密切。然而,心脏重构时发生能量代谢改变相关机制与意义仍亟待深入研究。除心力衰竭外,心肌肥厚、酒精性心肌病与心律失常亦存在代谢重构。本文就心脏能量代谢重构研究进展进行综述。

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金(81270252);; 黑龙江省教育厅项目(12521206)

作者(Author): 李为民,刘怡希

参考文献(References)：

• [1]Bilsen M,Smeets P,Gilde A,et al.Metabolic remodeling of the failing heart:the cardiac burn-out syndrome?[J].Cardiovasc Res,2004,61(2):218-226.
• [2]Neubauer S.The failing heart—an engine out of fuel[J].N Engl J Med,2007,356(11):1140-1151.
• [3]Doenst T,Pytel G,Schrepper A,et al.Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload[J].Cardiovasc Res,2010,86(3):461-470.
• [4]Bugger H,Schwarzer M,Chen D,et al.Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure[J].Cardiovasc Res,2010,85(2):376-384.
• [5]Deoenst T,Abel ED.Spotlight on metabolic remodeling in heart failure[J].Cardiovasc Res,2011,90(2):191-193.
• [6]Neubauer S,HornM,Crammer M,et al.Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy[J].Circulation,1997,96(7):2190-2196.
• [7]Tuunanen H,Knuuti J.Metabolic remodeling in human heart failure[J].Cardiovasc Res,2011,90(2):251-257.
• [8]Davila-Roman VG,Vedala G,Herrero P,et al.Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy[J].J Am Coll Cardiol,2002,40(2):271-277.
• [9]Arany Z,He H,Lin J,et al.Transcriptional coactivator PGC-1αcontrols the energy state and contractile function of cardiac muscle[J].Cell Metab,2005,1(4):259-271.
• [10]Lionetti V,Stnnley WC,Recchia F.Modulating fatty acid oxidation in heart failure[J].Cardiovasc Res,2011,90(2):202-209.
• [11]Sihag S,Cresci S,Li AY,et al.PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart[J].J Mol Cell Cardiol,2009,46(2):201-212.
• [12]Marsin AS,Bertrand L,Rider MH,et al.Phosphorylation and activation of heart PFK-2by AMPK has a role in the stimulation of glycolysis during ischaemia[J].Curr Biol,2000,10(20):1247-1255.
• [13]Leistad E,Borgers M,Christensen G.Atrial contractile dysfunction after short-term atrial fibrillation can be explained by changes in intracellular calcium,but not by atrial ischemia[J].Circulation,1996,94:1386-1387.
• [14]Ausma J,Wijffels M,ThonéF,et al.Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat[J].Circulation,1997,96(9):3157-3163.
• [15]Cha YM,Dzeja PP,Shen WK,et al.Failing atrial myocardium:energetic deficits accompany structural remodeling and electrical instability[J].Am J Physiol Heart Circ Physiol,2003,284(4):H1313-H1320.
• [16]Mayr M,Yusuf S,Weir G,et al.Combined metabolomic and proteomic analysis of human atrial fibrillation[J].J Am Coll Cardiol,2008,51(5):585-594.
• [17]Barth AS,Tomaselli GF.Cardiac metabolism and arrhythmias[J].Circ Arrhythm Electrophysiol,2009,2(3):327-335.
• [18]祝善俊.代谢重构与慢性心力衰竭[J].中华老年心脑血管病杂志,2007,9(6):361-363.
• [19]Wiggers H,Norrelund H,Nielsen SS,et al.Influence of insulin and free fatty acids on contractile function in patients with chronically stunned and hibernating myocardium[J].Am J Physiol Heart Circ Physiol,2005,289(2):H938-H946.
• [20]El-Kady T,El-Sabban K,Gabaly M,et al.Effects of trimetazidine on myocardial perfusion and the contractile response of chronically dysfunctional myocardium in ischemic cardiomyopathy:a24-month study[J].Am J Cardiovasc Drugs,2005,5(4):271-278.
• [21]Phan TT,Shivu GN,Choudhury A,et al.Multicentre experience on the use of perhexilline in chronic heart failure and refractory angina:old drug,new hope[J].Eur J Heart Fail,2009,11(9):881-886.
• [22]Bansal M,Chan J,Leano R,et al.Effects of perhexiline on myocardial deformation in patients with ischaemic left ventricular dysfunction[J].Int J Cardiol,2010,139(2):107-112.
• [23]Al-Hesayen A,Azevedo ER,Floras JS,et al.Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure:differential effects on myocardial energy substrate utilization[J].Eur J Heart Fail,2005,7(4):618-623.